Top

Published in:

Open Access 01-12-2011 | Research article

Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey

Authors: Sophie Vaux, Dieter Van Cauteren, Jean-Paul Guthmann, Yann Le Strat, Véronique Vaillant, Henriette de Valk, Daniel Lévy-Bruhl

Published in: BMC Public Health | Issue 1/2011

Abstract

Background

Following the emergence of the influenza A(H1N1)2009 virus, the French ministry of health decided to offer free vaccination against pandemic influenza to the entire French population. Groups of people were defined and prioritised for vaccination.

Methods

We took a random sample of the population of mainland France and conducted a retrospective cross-sectional telephone survey to estimate vaccination coverage against seasonal and pandemic influenza and to identify determinants of these vaccinations.

Results

10,091 people were included in the survey. Overall seasonal influenza vaccination coverage (IVC) remained stable in the population from the 2008-2009 season to the 2009-2010 season reaching 20.6% and 20.8% respectively. Overall pandemic IVC in the French population is estimated to be 11.1% (CI95%: 9.8 - 12.4). The highest pandemic IVC was observed in the 0-4 years age group. For individuals with health conditions associated with higher risk of influenza, pandemic IVC was estimated to be 12.2% (CI95%: 9.8 - 15.1). The main determinants associated with pandemic influenza vaccine uptake were: living in a household with a child < 5 years OR_adj: 2.0 (CI95%: 1.3 - 3.1) or with two children < 5 years or more, OR_adj: 2.7 (CI95%: 1.4 - 5.1), living in a household where the head of the family is university graduate (>2 years), OR_adj: 2.5 (CI95%: 1.5 - 4.1), or has a higher professional and managerial occupation, OR_adj: 3.0 (CI95%: 1.5 - 5.5) and being vaccinated against seasonal influenza, OR_adj: 7.1 (CI95%: 5.1 - 10.0). Being an individual with higher risk for influenza was not a determinant for pandemic influenza vaccine uptake. These determinants are not the same as those for seasonal influenza vaccination.

Conclusions

Overall A(H1N1)2009 influenza vaccine uptake remained low, particularly among individuals with higher risk for influenza and was lower than that observed for seasonal influenza. The reasons behind people's reluctance to be vaccinated need to be investigated further.

Available only for authorised users

World Health Organization: Transcript of statement by Margaret Chan, Director-General of the Word Health Organization: WHO. 2009, accessed on April 15, 2010, [http://www.who.int/mediacentre/influenzaAH1N1_presstranscript_20090611.pdf]

New influenza A(H1N1) virus infections in France, April - May 2009. Euro Surveill. 2009, 14 (21):

Levy-Bruhl D, Vaux S: Modified surveillance of influenza A(H1N1)v virus infections in France. Euro Surveill. 2009, 14 (29):

Vaux S, Brouard C, Fuhrman C, Turbelin C, Cohen JM, Valette M, Enouf V, Caillère N, George S, Fonteneau L, Gallay A, Nicolau J, Herida M, Gastellu-Etchegorry M, Mailles A, Belanger F, Cardoso T, Rousset D, Bouscambert-Duchamp M, Mosnier A, Pelat C, Chiron E, Levy Bruhl D, Saura C: [Dynamics and impact of the A(H1N1)2009 epidemic in metropolitan France, 2009-2010]. Dynamique et impact de l'épidémie A(H1N1)2009 en France métropolitaine. Bull Epidemiol Hebd. 2010, French, 259-264. 24-25-26, 22 juin 2010:. [in French]

Haut Conseil de la Santé Publique: [Guidance on health priority setting for the use of pandemic vaccines against A(H1N1)v influenza virus]. Avis: Recommandations sur les priorités sanitaires d'utilisation des vaccins pandémiques dirigés contre le virus A(H1N1)v. 2009, Paris: HCSP, accessed on May 26, 2010. [in French], [http://www.hcsp.fr/docspdf/avisrapports/hcspa20090907_H1N1.pdf]

Code de la Santé Publique: Article L1121-1. Biomedical research. General principles. 2010, accessed on November 8, [http://www.legifrance.gouv.fr/affichCodeArticle.do?cidTexte=LEGITEXT000006072665&idArticle=LEGIARTI000021942025&dateTexte=20100429]

Fuhrman C, Bonmarin I, Paty AC, Duport N, Chiron E, Lucas E, Bitar D, Mailles A, Herida M, Vaux S, Levy-Bruhl D: Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. Euro Surveill. 2010, 15 (2):

Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, Fonseca VP, Ritger KA, Kuhles DJ, Eggers P, Bruce H, Davidson HA, Lutterloh E, Harris ML, Burke C, Cocoros N, Finelli L, MacFarlane KF, Shu B, Olsen SJ: H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009, 374 (9688): 451-458. 10.1016/S0140-6736(09)61304-0.CrossRefPubMed

Schwarzinger M, Flicoteaux R, Cortarenoda S, Obadia Y, Moatti JP: Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?. PLoS One. 2010, 5 (4): e10199-10.1371/journal.pone.0010199.CrossRefPubMedPubMedCentral

10.

Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M: Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010, 375 (9720): 1100-1108. 10.1016/S0140-6736(09)62126-7.CrossRefPubMed

11.

World Health Organization: WHO recommendations on pandemic (H1N1) 2009 vaccines. Geneva. 2010, accessed on June 16, [http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090713/en/index.html]

12.

Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H: [Influenza vaccination coverage in France in 2007-2008: contribution of vaccination refund data from the general health insurance scheme]. Med Mal Infect. 2009, 39 (10): 780-788. 10.1016/j.medmal.2009.08.013.CrossRefPubMed

13.

Lina B, Holm MV, Szucs TD: [Evolution of influenza vaccination coverage in France from 2001 to 2006]. Med Mal Infect. 2008, 38 (3): 125-132. 10.1016/j.medmal.2007.11.014. in FrenchCrossRefPubMed

14.

CORRUSS: [Influenza A (H1N1. Epidemiological situation and vaccine coverage. Update 04/05/2010.] Grippe A(H1N1). Situation épidémiologique et couverture vaccinale. point au 4/5/10. 2010, CORRUSS

15.

Bone A, Guthmann JP, Nicolau J, Levy-Bruhl D: Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine. 2010, 28 (51): 8157-8161. 10.1016/j.vaccine.2010.09.096.CrossRefPubMed

16.

Lagarde JC, Door JC: [Report on behalf of the Investigating Committe on the way in which the influenza A (H1N1) vaccination campaign was planned, justified and managed.] Rapport fait de la commission d'enquête sur la manière dont a été programmé, expliquée et gérée la campagne de vaccination contre la grippe A(H1N1). Assemblée nationale. Paris. 2010, accessed on July 30, 2010. [in French], [http://www.assemblee-nationale.fr/13/pdf/rap-enq/r2698.pdf]

17.

Centers for Disease Control and Prevention: Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. MMWR Morb Mortal Wkly Rep. 2010, 59 (12): 363-368.

18.

Department of Health: Pandemic H1N1 Vaccine Uptake Figures for England by SHA and PCT. 2010, Departement of Health, accessed on July 30, 2010, [http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_114212.pdf]

19.

Setbon M, Raude J: Factors in vaccination intention against the pandemic influenza A/H1N1. Eur J Public Health. 2010, 20 (5): 490-4. 10.1093/eurpub/ckq054.CrossRefPubMed

20.

Maurer J, Uscher-Pines L, Harris KM: Perceived Seriousness of Seasonal and A(H1N1) Influenzas, Attitudes Toward Vaccination, and Vaccine Uptake Among U.S. Adults: Does the Source of Information Matter?. Prev Med. 2010, 51 (2): 185-7. 10.1016/j.ypmed.2010.05.008.CrossRefPubMed

21.

Maurer J, Harris KM, Parker A, Lurie N: Does receipt of seasonal influenza vaccine predict intention to receive novel H1N1 vaccine: evidence from a nationally representative survey of U.S. adults. Vaccine. 2009, 27 (42): 5732-5734. 10.1016/j.vaccine.2009.07.080.CrossRefPubMedPubMedCentral

22.

Vaux S, Noel D, Fonteneau L, Guthmann JP, Levy-Bruhl D: Influenza vaccination coverage of healthcare workers and residents and their determinants in nursing homes for elderly people in France: a cross-sectional survey. BMC Public Health. 2010, 10: 159-10.1186/1471-2458-10-159.CrossRefPubMedPubMedCentral

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/11/30/prepub

Title: Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey
Authors: Sophie Vaux
Dieter Van Cauteren
Jean-Paul Guthmann
Yann Le Strat
Véronique Vaillant
Henriette de Valk
Daniel Lévy-Bruhl
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/1471-2458-11-30

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study

Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

Global challenges with scale-up of the integrated management of childhood illness strategy: results of a multi-country survey

Involvement and structure: A qualitative study of organizational change and sickness absence among women in the public sector in Sweden

Asking the right questions: developing evidence-based strategies for treating HIV in women and children

Institutional risk factors for norovirus outbreaks in Hong Kong elderly homes: a retrospective cohort study